Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014–2018)

Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014–2018)

Background: A few years after the introduction in Italy of a four-component anti-meningococcal B vaccine (4CMenB), we evaluated the effectiveness and impact of vaccination in two regions using different schedules (2, 4, 6, 12 months in Tuscany vs. 7, 9, 15 months in Veneto) through an observational...

Full description

Bibliographic Details
Main Authors: Chiara Azzari, Maria Moriondo, Francesco Nieddu, Valentina Guarnieri, Lorenzo Lodi, Clementina Canessa, Giuseppe Indolfi, Mattia Giovannini, Giuseppina Napoletano, Francesca Russo, Tatjana Baldovin, Silvia Cocchio, Silvia Ricci, Vincenzo Baldo
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Vaccines
Subjects:
meningococcus B
vaccination schedule
children
vaccine effectiveness
vaccine impact
Online Access:https://www.mdpi.com/2076-393X/8/3/469

Internet

https://www.mdpi.com/2076-393X/8/3/469

Similar Items